Hepatocellular carcinoma (HCC) is one of the most common and lethal malignant tumors in
the world. Therapeutic options for advanced HCC are limited. Systemic treatment, especially …

Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-associated death
worldwide. Angiogenesis, the process of formation of new blood vessels, is required for …

Periodontitis, an oral inflammatory disease, originates from periodontal microbiota dysbiosis
which is associated with the dysregulation of host immunoinflammatory response. This …

Simple Summary Prostate cancer is a leading cause of cancer-related deaths among men,
and novel therapies for advanced PCa are urgently needed. Cardiac glycosides are a group …

Cancer is one of the diseases with the highest morbidity and mortality rates worldwide, and
its therapeutic options are inadequate. The endothelial glycoprotein, also known as CD105 …

Mesenchymal stem/stromal cells (MSCs) represent a heterogeneous cell population
distributed throughout various tissues, demonstrating remarkable adaptability to …

CD105 (endoglin) is a transmembrane protein that functions as a TGF-beta coreceptor and
is highly expressed on endothelial cells. Unsurprisingly, preclinical and clinical evidence …

Background: Peritoneal fibrosis (PF) is an intractable complication in patients on long-term
peritoneal dialysis (PD). Transforming growth factor-β (TGF-β) is a key pro-fibrogenic factor …

Hepatocellular carcinoma (HCC) is the most common liver cancer as well as the most
prevalent cause of death in the adult patient population with cirrhosis. The occurrence of …

Tuberculosis (TB) management is important for prompt discrimination of latent TB infection
(LTBI) from active TB and proper treatment. Whole blood Interferon-gamma (IFN-γ) release …